Loncar Cancer Immunotherapy ETF’s (CNCR) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting Loncar Cancer Immunotherapy ETF is a Sell.
Loncar Cancer Immunotherapy ETF’s (CNCR) 20-Day exponential moving average is 14.48, making it a Buy.
Loncar Cancer Immunotherapy ETF’s (CNCR) 50-Day exponential moving average is 14.51, making it a Sell.